Valley National Advisers’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Valley National Advisers’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12K	Buy	+33	New	+$990	﹤0.01%	865
2023 Q4	–	Sell	-32	Closed	-$1K	–	1230
2023 Q3	$1K	Hold	32	–	–	﹤0.01%	946
2023 Q2	$1K	Hold	32	–	–	﹤0.01%	891
2023 Q1	$1K	Buy	+32	New	+$801	﹤0.01%	820
2022 Q4	–	Sell	-32	Closed	-$1K	–	908
2022 Q3	$1K	Hold	32	–	–	﹤0.01%	842
2022 Q2	$1K	Hold	32	–	–	﹤0.01%	825
2022 Q1	$1K	Sell	32 -1,175	-97%	-$41.5K	﹤0.01%	847
2021 Q4	$53K	Buy	+1,207	New	+$57.1K	0.01%	358

Other funds holding IDNA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Valley National Advisers's IDNA Position: Q2 2026 in Review

Valley National Advisers opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2026: 33 shares worth $1.12K. The stake represents ﹤0.01% of the portfolio and ranks #865 among its holdings. This is a return to the name: Valley National Advisers previously reported a position in IDNA as recently as Q3 2023.

Valley National Advisers first reported a position in IDNA in Q4 2021 and has held it in 8 quarters since. The position peaked at $53K in Q4 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

Valley National Advisers held 33 shares of iShares Genomics Immunology and Healthcare ETF worth $1.12K as of Q2 2026.
iShares Genomics Immunology and Healthcare ETF was a new Valley National Advisers position in Q2 2026.
iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #865 holding.
Valley National Advisers first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2021 and has held it in 8 quarters since.
Valley National Advisers's iShares Genomics Immunology and Healthcare ETF position peaked at $53K in Q4 2021.
66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.